00314 SIPAI HEALTH
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.91X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 2.1% | Net Margin | N/A |
Total Debt/Equity | 3.7% | Return on Equity | N/A |
Price/Book | 3.72X | Return on Assets | N/A |
(HKD 6.350) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -344.29 | -281.91 | -1,536.69 | -4,574.95 | -1,237.57 |
---|---|---|---|---|---|
Net Profit Growth (%) | -22.1 | +81.7 | +66.4 | -269.7 | -86.2 |
Earnings Per Share (HKD) | -0.539 | -0.438 | -13.662 | -46.003 | -12.376 |
Earnings Per Share Growth (%) | -23.1 | +96.8 | +70.3 | -271.7 | -86.2 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 1.706 | 2.343 | 2.699 | N/A | N/A |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 4,565 | 4,712 | -3.1 | 4,119 |
Operating Result | -358.687 | -244.254 | +46.9 | -1,369 |
Associates | -0.187 | -0.412 | -54.6 | 0.331 |
Profit Before Taxation | -360.641 | -245.666 | +46.8 | -1,368 |
Taxation | 1.191 | 1.041 | +14.4 | 3.322 |
Profit /( Loss) After Taxation | -361.832 | -246.707 | +46.7 | -1,372 |
Minority Interests | -38.096 | 9.061 | -520.4 | -1.192 |
Net Profit | -323.736 | -255.768 | +26.6 | -1,371 |
Earnings Per Share () | -0.5388 | -0.4377 | +23.1 | -13.6624 |
Announcement Date | 2025-03-18 | 2024-03-19 | NA | 2023-03-15 |
* Annualised
Last Update Time: 2025-07-22 21:40:25